NASDAQ:MEIP
MEI Pharma Stock News
$3.15
+0.220 (+7.51%)
At Close: May 17, 2024
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ: BMRA ) Centogene NV (NASD
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 19.)
Biomerica, Inc. (NASDAQ...
Stocks That Hit 52-Week Lows On Thursday
02:49pm, Thursday, 19'th Mar 2020
On Thursday morning, 1178 companies hit new 52-week lows.
Facts of Interest:
The largest company by market cap to set a new 52-week low was Nuveen Preferred & Income...
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
11:37am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commen
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
Those Who Purchased MEI Pharma (NASDAQ:MEIP) Shares Five Years Ago Have A 81% Loss To Show For It
01:04pm, Friday, 13'th Mar 2020
Long term investing is the way to go, but that doesn't mean you should hold every stock forever. It hits us in the gut...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
New Covid-19 Cases Increase, 5 Defensive Stocks to Buy
03:03pm, Thursday, 13'th Feb 2020
Here are five defensive stocks that can shield your portfolio as Covid-19 continues to spread, instilling volatility in the stock market.
MEI Pharma Reports Fiscal Second-Quarter 2020 Results and Operational Highlights
09:02pm, Thursday, 06'th Feb 2020
MEI Pharma, Inc. (NASDAQ: MEIP) ("MEI"), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for its second quarter ended December 31, 2019.
MEI Pharma Q2 EPS $(0.26) Down From $(0.15) YoY, Sales $1.008M Down From $2.048M YoY
12:00am, Thursday, 06'th Feb 2020Enacting Digital Services Tax More Than Just a Waiting Game for Canada
08:41pm, Wednesday, 29'th Jan 2020
Imposing a digital services tax on corporate revenue has a poor track record of hitting the mark, says Jack Mintz.